You can buy or sell Bio-Techne and other stocks, options, ETFs, and crypto commission-free!
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. Read More The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.
52 Week High
52 Week Low
Oil and Gas
Yahoo FinanceMay 21
Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference
MINNEAPOLIS, May 21, 2019 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5th, 2019, at 9:30 a.m. EDT. The conference will be held at the Grand Hyatt Hotel in New York City.
Yahoo FinanceMay 14
Does Bio-Techne Corporation's Past Performance Indicate A Stronger Future?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Measuring Bio-Techne Corporation's (NASDAQ:TECH) track record of past performance is a valuable exercise for investors. It allows us to understand whether or not the company has met or exceed expectations, which is an insightful signal for future performance. Today I will assess TECH's recent performance announced on 31 March 2019 and compare these figures to its historical trend and ...
Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 09, 2019
Bio-Techne Corp ( TECH ) will begin trading ex-dividend on May 09, 2019. A cash dividend payment of $0.32 per share is scheduled to be paid on May 24, 2019. Shareholders who purchased TECH prior to the ex-dividend date are eligible for the cash dividend payment.
Expected Aug 6, Pre-Market